Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Burçak KILIÇKIRAN AVCI"'
Autor:
Yalın Tolga Yaylalı, Burcu Yağmur, Ümit Yaşar Sinan, Murat Meriç, İbrahim Başarıcı, Burçak Kılıçkıran avcı, Hande Şenol, Sanem Nalbantgil, Serdar Küçükoğlu, Zeki Öngen
Publikováno v:
Anatolian Journal of Cardiology, Vol 27, Iss 8, Pp 479-485 (2023)
Background: Risk assessment is recommended for patients with congenital heart disease-associated pulmonary arterial hypertension. This study aims to compare an abbreviated version of the risk assessment strategy, noninvasive French model, and an abri
Externí odkaz:
https://doaj.org/article/a8b1578742394b6fa601b5f46e5327e1
Autor:
Eser Durmaz, Bilgehan Karadağ, Cansu Ebren, Burçak Kılıçkıran Avcı, Burak Koçak, Ece Yurtseven, Damla Koca, Utku Raimoğlu, Mehmet Semih Belpınar, Zeki Öngen
Publikováno v:
İstanbul Medical Journal, Vol 21, Iss 6, Pp 436-442 (2020)
Introduction:Atrial fibrillation (AF) is one of the most important causes of ischaemic stroke according to the TOAST classification. The CHA2DS2-VASc score is a widely used scoring system for estimating systemic thromboembolism in patients with non-v
Externí odkaz:
https://doaj.org/article/9337b3fa76f84488868063a1568e30f3
Autor:
Murat Cimci, Sermin Borekci, Burcak Kilickiran Avci, Ergi Hysi, Hurrem Gul Ongen, Bilgehan Karadag, Ozge Ozden Tok, Eser Durmaz, Hakan Karpuz
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 48, Iss 3, Pp 263-269 (2020)
Objective: Chronic obstructive pulmonary disease (COPD) is associated with atrial fibrillation (AF) and reduced forced expiratory volume (FEV1) is an independent predictor for new onset AF. The aims of this study were (1) to analyze the atrial electr
Externí odkaz:
https://doaj.org/article/5eca9da5d6064ecca9896cf4e1715e46
Autor:
Hasan Ali Barman, Barış İkitimur, Burçak Kılıçkıran Avcı, Eser Durmaz, Adem Atıcı, Serkan Aslan, Serdar Ceylaner, Hakan Karpuz
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 6, Pp 354-358 (2019)
Aims: Fabry disease is an X-linked lysosomal storage disorder due to a deficiency of the α-galactosidase A enzyme. Cardiac involvement is present in over 60% of adult cases of Fabry disease. Hypertrophic cardiomyopathy without left ventricular outfl
Externí odkaz:
https://doaj.org/article/a8407db3f40d4df384a647ade6f98e6c
Publikováno v:
İstanbul Medical Journal, Vol 20, Iss 6, Pp 528-534 (2019)
Introduction:This study aimed to investigate the left ventricular function and electrocardiographic findings in patients with chronic leukemia receiving and not receiving chemotherapy during a one-year follow-up.Methods:A total of 111 patients with c
Externí odkaz:
https://doaj.org/article/bc5b7fc82ba54ffd9b24e7ae5a2cd4e9
Autor:
Pınar Kızılırmak, Yağız Üresin, Oktay Özdemir, Burçak Kılıçkıran Avcı, Lale Tokgözoğlu, Zeki Öngen
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 45, Iss 1, Pp 49-66 (2017)
Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes. M
Externí odkaz:
https://doaj.org/article/3db48cbc4e1f480bb4b89d6e38e277a8
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 11, Pp 1311-1315 (2016)
Background: Hypertension (HT) is associated with atrial electrophysiological abnormalities. Echocardiographic pulsed wave tissue Doppler imaging (TDI) is one of the noninvasive methods for evaluation of atrial electromechanical properties. The aims o
Externí odkaz:
https://doaj.org/article/f970dbb7dda94926b830ca5ef44eae29
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 42, Iss 4, Pp 399-402 (2014)
Unilateral absence of the pulmonary artery and interrupted inferior vena cava are rare congenital disorders. The clinical presentation is variable, and many patients can be asymptomatic for many years and even throughout their lives. We report the ca
Externí odkaz:
https://doaj.org/article/6ed3c1f2c1624eec9cb1b27fb4c93ee1
Autor:
Yalın Tolga YAYLALI, İbrahim BAŞARICI, Burçak KILIÇKIRAN AVCI, Murat MERİÇ, Ümit YAŞAR SİNAN, Hande ŞENOL, Mehmet Serdar KÜÇÜKOĞLU, Zeki ÖNGEN
Objective: Risk stratification continues to evolve in pulmonary arterial hypertension (PAH). Our aim was to further confirm the risk assessment strategy in our cohort and to determine the most reliable model.Methods: We enrolled incident patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::59bf6c13aeaa75f46050eed3bee022eb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.